Atropos Health

Atropos Health

Rapid physician consultations using real-world data

Overview

Atropos Health delivers physician-focused real-world evidence through a digital consultation service that helps clinicians answer complex questions by querying patient data. Clinicians submit a clinical question and, within 24 hours, receive insights derived from observational research and real-world data developed over five years at Stanford. The service is offered on a subscription basis to healthcare providers, hospitals, and research institutions, with potential partnerships with pharmaceutical companies. Its goal is to close the evidence gap in medical decision-making by making real-world data actionable for physicians, researchers, and healthcare organizations.

Significant Headcount Growth

About Atropos Health

Simplify's Rating
Why Atropos Health is rated
B-
Rated B on Competitive Edge
Rated B on Growth Potential
Rated C on Differentiation

Industries

Data & Analytics

Enterprise Software

Healthcare

Company Size

51-200

Company Stage

Series B

Total Funding

$47M

Headquarters

Palo Alto, California

Founded

2019

Simplify Jobs

Simplify's Take

What believers are saying

  • Guidehouse and Microsoft integrations expand point-of-care distribution across health systems.
  • First-edition partners could reach one-third of U.S. physicians and half of major systems.
  • Commercial Analytics opens life-science revenue from HEOR, R&D, and brand decisions.

What critics are saying

  • Microsoft can internalize evidence workflows and relegate Atropos to backend infrastructure.
  • The 2 billion artifact target by end-2026 invites credibility loss if delivery slips.
  • A single EHR hallucination or safety failure will trigger immediate clinician and compliance backlash.

What makes Atropos Health unique

  • Alexandria holds 33 million precision evidence artifacts, built from standardized observational workflows.
  • Atropos embeds evidence inside Microsoft Teams, Dragon Copilot, and EHR workflows.
  • The Evidence Agent answered 5,000 clinician questions using evidence better than GPT and Claude.

Help us improve and share your feedback! Did you find this helpful?

Funding

Total Funding

$47M

Meets

Industry Average

Funded Over

2 Rounds

Series B funding is typically for startups that have proven their business model and need more funding to expand rapidly—often by entering new markets or adding more products. Investors are usually venture capital firms that specialize in later-stage investments.
Series B Funding Comparison
Meet Average

Industry standards

$35M
$33M
Atropos Health
$45M
Linktree
$65M
Substack
$100M
ClickUp

Benefits

Health Insurance

Dental Insurance

Vision Insurance

Life Insurance

401(k) Retirement Plan

Parental Leave

Flexible Work Hours

Remote Work Options

Home Office Stipend

Growth & Insights and Company News

Headcount

6 month growth

1%

1 year growth

6%

2 year growth

6%
The Associated Press
Mar 10th, 2026
Atropos Health integrates AI-powered evidence agent with Microsoft Dragon Copilot at Stanford Medicine

Atropos Health has announced a collaboration with Microsoft Dragon Copilot at Stanford Medicine, integrating its Evidence Agent into the electronic health record system. The AI-powered tool provides physicians with personalised real-world evidence at the point of care, drawing from Stanford's clinical data including information generated by Dragon Copilot. The Atropos Evidence Agent is now available in the Microsoft Teams Store, allowing clinicians to download it for care team collaboration. The technology generates evidence-based summaries relevant to individual patients without disrupting clinical workflow. Atropos Health, which operates GENEVA OS for rapid healthcare evidence generation, is part of Microsoft's invite-only Pegasus Program for startups. The company is demonstrating the capability at the 2026 HIMSS conference in Las Vegas.

Atropos Health
Feb 5th, 2026
Atropos Health Announces Key New Hires to Scale High Quality Evidence Utilization in the Healthcare Ecosystem

Atropos Health announces key new hires to scale high quality evidence utilization in the healthcare ecosystem. Atropos Health announces the addition of two new hires to the leadership team, including the company's first Chief Technology Officer and Chief Financial Officer. Sylvia Isler joins as Chief Technology Officer and Drew Turitz as Chief Financial Officer. The addition of these two team members expands the companies' domain knowledge across the healthcare ecosystem including telehealth, payers and big tech.

The Associated Press
Feb 5th, 2026
Atropos Health appoints first CTO and CFO to scale real-world evidence platform

Atropos Health, a company translating real-world clinical data into personalised evidence, has appointed Sylvia Isler as Chief Technology Officer and Drew Turitz as Chief Financial Officer. The hires expand the company's expertise across telehealth, payers and big tech. Isler brings over 20 years of experience leading engineering and IT organisations at Google, Better Life Partners and Cityblock Health. She holds a PhD in Computer Science from the University of Massachusetts Lowell. Turitz has more than 20 years in healthcare finance, previously serving as CFO of Fuze Health and spending a decade at Teladoc leading corporate development. He earned an MBA from Northwestern University's Kellogg School of Management. The appointments follow Atropos Health's recent hire of Kevin Smith as Chief Growth Officer.

Atropos Health
Feb 3rd, 2026
Atropos Health Named to the 2026 New York Digital Health 100

Atropos Health named to the 2026 New York Digital Health 100. Atropos Health has been named to the 2026 New York Digital Health 100 (DH100), an annual recognition honoring the most innovative and high-impact digital health startups in the New York region. Published by Digital Health New York (DHNY), the DH100 is released in conjunction with the 2026 New York Healthcare Innovation Report, which analyzes key investment trends, market dynamics, and opportunities shaping the digital health ecosystem.

Atropos Health
Jan 12th, 2026
Atropos Health Announces AI-Driven Commercial Analytics Solution for Life Science Companies

Atropos Health announces ai-driven Commercial Analytics solution for life science companies. Atropos Health today announced the availability of Commercial Analytics solutions for life science leaders. This is an extension to the already growing number of solutions available to life science companies to accelerate decision making across the Real World Data(RWD), Research & Development (R&D), Health Economics and Outcomes Research (HEOR)/Medical, and Brand use cases. The solution leverages the speed and accuracy of ChatRWD(R) to generate rapid answers while transparently displaying actionable insights. Commercial and brand leaders generate high-quality, brand-specific insights delivered in seconds with not only the visuals they need - but also the data behind the dashboards.

Recently Posted Jobs

Sign up to get curated job recommendations

Atropos Health is Hiring for 2 Jobs on Simplify!

Find jobs on Simplify and start your career today

Don't see your dream role? Check out thousands of other roles on Simplify. Browse all jobs →